Lv1
40 积分 2024-04-09 加入
Enhancer of Zeste Homolog 2 Inhibitor SHR2554 in Relapsed or Refractory Peripheral T-cell Lymphoma: Data from the First-in-Human Phase I Study
2个月前
已完结
Causal Assessment of Phenotypic Risk Factors with Keratinocyte Carcinoma
3个月前
已完结
Number needed to test: quantifying risk stratification provided by diagnostic tests and risk predictions
3个月前
已完结
Enhancer of Zeste Homolog 2 Inhibitor SHR2554 in Relapsed or Refractory Peripheral T-cell Lymphoma: Data from the First-in-Human Phase I Study
7个月前
已完结
Cutaneous T Cell Lymphoma Following Dupilumab Therapy in Patients with Atopic Dermatitis: Clinical Review and Recommendations
7个月前
已关闭
Abrogation of USP9X Is a Potential Strategy to Decrease PEG10 Levels and Impede Tumor Progression in Cutaneous T-Cell Lymphoma
7个月前
已完结
皖公网安备34019202002308
